Oxidative Stress Markers in Prostate Cancer Patients after HDR Brachytherapy Combined with External Beam Radiation

الملخص EN

Assessment of oxidative stress markers was perfomed in prostate cancer (PCa) patients subjected to high-dose brachytherapy (HDR) with external beam radiotherapy (EBRT).

Sixty men with PCa were subjected to combined two-fraction treatment with HDR (tot.

20 Gy) and EBRT (46 Gy).

Blood samples were taken before treatment, immediately afterwards, after 1.5–3 months, and approx.

2 years.

Control group consisted of 30 healthy men.

Erythrocyte glutathione peroxidase activity in the patients was lower than in healthy subjects by 34% (P<0.001), 50% (P<0.001), 30% (P<0.05), and 61% (P<0.001), respectively, at all periods.

No significant differences were found by comparing superoxide dismutase and catalase activity in PCa patients with that of the controls.

After 2 years of the end of treatment, the activity of studied enzymes demonstrated a decreasing tendency versus before therapy.

Blood plasma thiobarbituric acid reactive substances (TBARS) concentration was higher than in the controls at all periods, while erythrocyte TBARS decreased after 2 years to control levels.

The results confirm that in the course of PCa, imbalance of oxidant-antioxidant processes occurs.

The therapy did not alter the levels of oxidative stress markers, which may prove its applicability.

Two years is too short a period to restore the oxidant-antioxidant balance.